Post-COVID drug shortages in the US offer opportunity for India, says Pharmexcil
Several US pharmaceutical companies closed some manufacturing sites post-COVID due to unprofitable operations, leading to a drug shortage, and India can meet this increasing demand, said Uday Bhaskar, Director General of the Pharmaceuticals Export …